JLB & Associates’s Clorox CLX Stock Holding History

JLB & Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,600	Closed	-$299K	–	75
2013 Q2	$299K	Buy	+3,600	New	+$310K	0.14%	70

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

JLB & Associates's CLX Position: Q3 2013 in Review

JLB & Associates sold out of Clorox (CLX) in Q3 2013, closing a stake of 3,600 shares — an estimated $299K sold.

JLB & Associates first reported a position in CLX in Q2 2013 and held it in 1 quarter. The position peaked at $299K in Q2 2013. 607 funds tracked by Wall St. Rank hold CLX as of Q3 2013.

JLB & Associates reported no remaining Clorox position as of Q3 2013 after selling out during the quarter.
JLB & Associates sold 3,600 Clorox shares in Q3 2013, an estimated $299K.
JLB & Associates first reported a position in Clorox in Q2 2013 and held it in 1 quarter.
JLB & Associates's Clorox position peaked at $299K in Q2 2013.
607 funds tracked by Wall St. Rank held Clorox as of Q3 2013.

Based on JLB & Associates's 13F filing for Q3 2013, filed 7 Oct 2013.